Transcript
Meta Ray Ban Display Announcer (0:01)
Introducing Meta Ray Ban Display, the world's most advanced AI glasses with a full color display built into the lens of the glasses. It's there when you need it and gone when you don't. Send and receive messages, translate or caption live conversations, collaborate with Meta AI and more. Be one of the first to try Meta Ray ban display. Visit meta.com metaraybanddisplay to book a demo and find your pair.
Marshall's Commercial Narrator (0:30)
Marshall's buyers are hustling hard to get amazing new gifts into stores right up to the last minute. Like a designer perfume for that friend who never RSVP'd wishlist topping toys for her kids who came too.
Dr. Chapa (0:42)
Mm.
Marshall's Commercial Narrator (0:43)
Belgian chocolates for the neighbor, a cozy scarf for your boss and a wool jacket for your husband that you definitely did not almost forget. Marshalls, we get the deals, you give the good stuff even at the last minute. Find a Marshall's near you.
Newspaper Seller / Announcer (1:08)
X ray. X Ray. Read all about it.
Dr. Chapa (1:10)
Podcast Family. You all know that one of our missions here, in addition to reviewing brand new studies or publications or new guidances, is to let you know what is hot in press, even in the vein or in the avenue of new medications. And that's exactly what we're going to cover in this episode.
Newspaper Seller / Announcer (1:31)
Extra, extra. Read all about it.
Dr. Chapa (1:33)
Yep, we're doing this on December 15th, 2025. Woo hoo. Ten days until Christmas. And just over the last few days, there's been a lot of progress on the war against gonorrhea. I don't know, I don't know if there's a war in gonorrhea or not, but maybe there should be. But this is new weapons in that arsenal against something that we were really concerned about because of the rise in resistan in that bad bug. Okay. And so in that same vibe, two medications were recently FDA approved. I'm talking about one on December 13th and then the other one just prior to that on December 11th. Let's do the first one that was approved first. That was Jepotitizen. That was called Blue Jiba by its brand name. Now if you remember, if you follow the show, we covered Blue Jiba months ago. Months ago because it already has a separate indication and approval for uti. So you gotta go back into the archives because we talked about, even though we'll just briefly mention it again, the mechanism of action is pretty novel. For Blue Jipa, that was FDA approved first for UTI. Now for oral treatment for gonorrhea, that was on December 11th. Then two days after that, the FDA gave another stamp of approval for For Zoliflotison, Zola Flauticin's brand name is New Volvins. What? New Zolvens. Yeah. All right. N U, Z O, L V E N C E. Nuzolvents, you try to figure that out anyway, even though Blue Jeepa is pretty catchy. Blue Jeepa, but Nuzolvents, I'm not digging that too much, but nonetheless, these are two brand new oral treatments for gonorrhea which are desperately needed because for people who don't like shots or whatever or they say they're gonna get it and then they don't get the first line of medication which is still ceftriaxone and it is weight based. Remember that under 150 kilos, then the dose for ceftriaxone is 500 milligrams. And if you're above 150 kilos, not pounds, but kilos, then you move up the dose of ceftriaxone to 1 gram. Im so we're briefly gonna talk about these two FDA appro jepotitazin, which was on December 11, and then two days later on December 13, zolifloticin, which were both approved as oral treatments for gonorrhea. Gonococcus. All right, so briefly, just a quick word on what is up because once again our goal here is let you know what is hot hot in not just in press, but also in the approval process.